January 8, 2015 — The Musculoskeletal Transplant Foundation (MTF) Wound Care division announced today that it has signed a group purchasing agreement with Premier, Inc., a leading healthcare improvement company. The agreement offers Premier alliance members access to MTF Wound Care’s innovative line of biologic tissue forms.
MTF Wound Care will initially offer Premier alliance members access to two tissue forms: AmnioBandTM Membrane, a human derived allograft placental matrix and AlloPatchTM Pliable, a human derived allograft dermal matrix.
“This is an exciting extension of our existing Premier partnership,” said Kim Rounds, Vice President of MTF Wound Care. “We can now bring innovative and healing wound care solutions to Premier’s patients and surgeons—many of whom already choose a broad selection of MTF tissues for their patients.”
According to the National Institute of Health (NIH), treating chronic wounds is a growing concern, fueled by increasing costs, an aging population and a sharp rise in such conditions as obesity and diabetes. NIH reports that in the United States alone, more than $25 billion is spent annually to treat chronic wounds.
Given the mounting need, MTF Wound Care is dedicated to developing highly advanced, safe, clinically based and cost-effective wound care solutions that work in concert with the body’s natural healing process.
MTF Wound Care is a division of MTF, the nation’s leading tissue bank. MTF supplies specialty donated human tissue for use by surgeons in orthopedic, spine, plastic and general surgery and sports medicine procedures. Founded by surgeons over 25 years ago, MTF maintains strict standards for donor recovery criteria and tissue processing. With over 100,000 donors recovered and over six million grafts distributed since its founding, MTF has maintained an exemplary reputation for safety and quality.
December 22, 2014 — The Musculoskeletal Transplant Foundation (MTF) announced today the launch of MTF Wound Care—a new MTF division dedicated to researching, developing and providing allograft-based, biologic solutions to treat acute and chronic wounds.
MTF Wound care is a natural extension of MTF—the non-profit is the nation’s leading tissue bank supplying specialty donated human tissue for orthopedics, spine, plastic surgery, general surgery, sports medicine, and beyond. Founded and run by physicians, MTF maintains strict standards for donor recovery criteria and tissue processing. With over 100,000 donors recovered and over six million grafts distributed since its founding, MTF has maintained an exemplary reputation for safety and quality.
According to Kim Rounds, Vice President of MTF Wound Care, the organization will initially offer two tissue forms: AmnioBandTM Membrane, a human derived allograft placental matrix; and AlloPatchTM Pliable, a human derived allograft dermal matrix. Both will be available in January 2015.
“These two innovative tissue forms are excellent examples of what we can bring to wound care professionals and their patients,” said Ms. Rounds. “Both AmnioBand and AlloPatch work in concert with the body’s natural healing process. They are the first of what we plan to be a broad and differentiated portfolio of offerings for wound care. Our focus, as always, is to develop solutions that are highly advanced, safe, clinically based and cost effective.”
According to the National Institute of Health (NIH), treating chronic wounds is a growing concern, fueled by increasing costs, an aging population and a sharp rise in such conditions as obesity and diabetes. NIH reports that in the United States alone, more than $25 billion is spent annually to treat chronic wounds.
Diabetes is a particular concern among wound care professionals, because the condition contributes directly and most heavily to the growing wound care problem:
• The World Health Organization (WHO) estimates that there are about 347 million people with
diabetes worldwide, and that number is expected to rise considerably by 2030.
• About 25% of people with diabetes will suffer a lower extremity ulcer over their lifetime. Since healing
is typically slow in diabetics, there’s an increased risk of infection and a higher risk for amputation.
In fact, diabetic ulcers precede 85% of lower extremity amputations.
“The statistics are sobering,” said MTF President and CEO Bruce Stroever. “It is at the core of MTF’s mission to do all we can to help patients in need. Through the generous gift of tissue donation, MTF can develop advanced, biologic tissue forms designed to optimally support the wound-healing process. We can make treating wounds better and more effective for everyone: patient and practitioner alike.”
To learn more about MTF Wound Care, contact Kim Rounds, Vice President, MTF Wound Care at email@example.com.
December 1, 2014 — The Musculoskeletal Transplant Foundation (MTF) announced today that Naomi Kurlowich of Columbia, SC, a tissue transplant recipient, will represent MTF for the Donate Life Float at the 2015 Tournament of Roses Parade in Pasadena, CA.
Diagnosed at birth with Down Syndrome, Naomi Kurlowich, never let it slow her down, from playing on a local softball team for children to being a physically active student at school.
Around her eighth birthday, Naomi began to experience painful dislocations of her kneecaps, also known as patellofemoral instability, while playing the sports she loves so much. The frequency and severity of the episodes increased as the ligaments supporting her patella became weaker with each dislocation.
A nasty fall right before her 15th birthday left her wheelchair-bound and her parents were advised that a more aggressive approach was needed. Their surgeon explained that Naomi's ligaments were too weak to reconstruct and suggested using donated tissue to fix the problem.
Naomi had the surgery to repair both of her knees a few months apart. She received tissue from two donors to strengthen and stabilize her knees. As her parents watched her recover, they marveled at the thought that two families had made the most selfless gift of donation, which gave their daughter a new lease on life.
"After a few weeks of physical therapy, Naomi progressed to a walker and the wheelchair was history," said Carol Kurlowich, Naomi's mother. "Two years later it still makes my heart sing to watch her run exuberantly around a ball field and up and down a basketball court."
Today, Naomi is an active 17-year-old who can walk, run and play softball, all from the generous gift of tissue donation from two donors and their families.
“We are delighted to sponsor Naomi and to support the Donate Life Float at the Tournament of Roses Parade. Her story highlights the incredible gift of tissue donation and the importance of the work done at MTF," said Martha Anderson, Executive Vice-President, Donor Services.
To see a video about Naomi and her story, go to https://www.youtube.com/watch?v=8SXAmNJ6vng
The Musculoskeletal Transplant Foundation (MTF), the world’s leading tissue bank announces the recipients of its 2014 Research Grants. Since 1987, MTF has been at the forefront of research focused on the transplantation of donated human tissue, with approximately $38 million awarded through 2013. MTF anticipates awarding close to $2 million in grants and awards in the 2014 calendar year. The 2014 grant recipients approved for funding are as follows:
PEER REVIEW – ESTABLISHED INVESTIGATOR
This is a multi-year program for any researcher who has previously been funded by a foundation or a federal agency and has published in a peer-reviewed journal as a Principal investigator.
Heike Daldrup-Link, M.D., Ph.D., Stanford University, Imaging Immune Responses to Stem Cell Mediated Bone Repair, $300,000
Henry Donahue, Ph.D., Pennsylvania State University, Hydroxyapatite Nanotopographies to Enhance Allograft Osteointegration, $299,185
Sang Jin Lee, Ph.D., Wake Forest School of Medicine, Allogeneic Decellularized Tissue Scaffolds for Reconstruction of Volumetric Muscle Loss, $300,000
J.R. NEFF AWARD
The J.R. Neff Award is named in honor of James R Neff, M.D. who was a highly respected, innovative orthopaedic surgeon and researcher. During much of his tenure as Chairman of Orthopaedics at the University of Nebraska Medical Center, he served on MTF’s Medical Board of Trustees and Board of Directors.
Chunfeng Zhao, M.D., Mayo Clinic, Rochester, Synovialization and Revitalization of Tendon Allograft for Flexor Tendon Reconstruction, $300,000
PEER REVIEW – JUNIOR INVESTIGATOR
This is a one-year award for any Ph.D. or M.D. who is post-graduate work or residency and who has never obtained an award from a foundation or a federal agency.
Alan Getgood, M.D., Fowler Kennedy Sport Medicine Clinic (London, Ontario), Techniques to Reduce Meniscus Extrusion During Meniscus Allograft Transplantation, $51,702
Karin Payne, Ph.D., University of Colorado, Revitalization of Bone Allograft with Induced Pluripotent Stem Cells to Enhance Spinal Fusion, $100,000
The Career Development Award is granted to an orthopaedist interested in pursuing and developing an academic career.
Frank Petrigliano, M.D., The Regents of the University of California, Los Angeles (UCLA), Evaluation of Structural Fibroblasts and Ligament Stem Cells for Tissue Engineering of the Anterior Cruciate Ligament, $300,000
Since 2000, MTF has provided the Orthopaedic Research and Education Foundation (OREF) with one $100,000 unrestricted research grant to aid an investigator in funding their orthopaedic research project.
Abhijit Dighe, Ph.D., University of Virginia, Interaction Between Mesenchymal Stem Cells and T Cells During Osteogenesis, $100,000
Through the Orthopaedic Research Education Foundation, two $20,000 grants are awarded in the name of our first President, Charles H. Herndon, M.D., for orthopaedic resident research projects.
Alekos Theologis, M.D., University of California, San Francisco, The Effect of the Endocrine Disrupting Chemical Bisphenol A (BPA) on Endochrondral Ossification in Fracture Repair, $20,000
Nathan Skelly, M.D., Washington University (St. Louis) Biomechanical Analysis of Tensile Properties and Fiber Alignment in the Anterior Cruciate Ligament to Map Ligament Bundle Design, $20,000
For more information on MTF’s research grant program, contact Hans Burchardt, Ph.D., Vice-President, Scientific Affairs (570-496-3434) or Hans_Burchardt@MTF.org ), or go to the MTF website (www.MTF.org ).
Edison, NJ, March 2014 — Bruce Stroever, President and CEO of the Musculoskeletal Transplant Foundation (MTF) today announced the appointment of Alan Milinazzo, President of InspireMD, and Tracy Schmidt, CEO of Intermountain Donor Services to the MTF Board of Directors.
“We are honored to welcome Alan Milinazzo to the MTF Board,” said William W. Tomford, MD, Chairman of the MTF Board of Directors. “With more than 25 years of executive management experience in the life sciences sector, his business acumen and experience with medical device companies will bring added depth to our board. As MTF’s business becomes increasing complex, Alan’s expertise will be of critical importance to the Board.”
Prior to his position at InspireMD, Milinazzo served as CEO of Orthofix International. He spent 12 years with Boston Scientific Corporation in a variety of executive roles, including Vice President of Marketing for SCIMED Europe. Milinazzo also worked for Medtronic Inc. serving first as Vice President of Medtronic Inc.’s vascular business, and then as Vice President and General Manager of Medtronic’s coronary and peripheral businesses. He was instrumental in the development and commercialization of a number of key products while at Medtronic, including the company’s first drug coated stent platform, Endeavor. Mr. Milinazzo is a cum laude graduate of Boston College.
“It’s a privilege to welcome Tracy Schmidt to the Board of Directors,” said Bruce Stroever, CEO of MTF. “Tracy’s experience with and understanding of the intricacies of organ and tissue donation and his commitment to excellence in service to donors, families and recipients will bring an added dimension to our Board.”
As CEO of Intermountain Donor Services, an organ procurement organization dedicated to the recovery and transplantation of organs and tissues, Tracy Schmidt helped start one of the first fully integrated donor registries in the United States for the states of Utah and Idaho. He also was instrumental in the successful passage of state legislation to support donation. Tracy has served on MTF’s Medical and Donation Boards of Trustees and has served as the Chair of MTF’s Ethics Committee. Prior to his position at Intermountain Donor Services, Tracy spent eight years as a hospital administrator for the Kaiser Foundation Hospital in Panorama City, California. Mr. Schmidt is a magna cum laude graduate of University of Utah and holds a MHA from the University of Minnesota.
“Both Alan and Tracy are proven leaders who will bring outstanding expertise and experience to the MTF Board as it continues to oversee the Foundation’s mission of providing the highest quality tissue grafts and advancing the science of transplantation,” Stroever said.
The Musculoskeletal Transplant Foundation, a non-profit organization based in Edison, NJ, is a national consortium comprised of leading organ procurement organizations, tissue recovery organizations and academic medical institutions. Since its inception in 1987, MTF has received tissue from more than 100,000 donors and distributed more than 5 million grafts for transplantation. For more information, visit www.mtf.org.
MTF presents Excellence in Donor Family Care Award to Warren and Diane Forsyth and Gift of Life Family Transport
Edison, NJ, December 2013 — The Musculoskeletal Transplant Foundation (MTF) announced today that the winners of the 2013 Nicholas Miller Award for Excellence in Donor Family Care are Diane and Warren Forsyth of Staten Island, NY and their foundation, the Gift of Life Family Transport.
In 2006, the Forsyth’s sixteen year old daughter, Amanda, a promising athlete, was struck by a car as she and three friends crossed Richmond Avenue in New Springville, after leaving a friend’s sweet 16 party. When Amanda’s accident occurred, the New York City Fire Department stepped in and provided 24-hour transportation services for her family as Warren Forsyth is a retired FDNY firefighter. This enabled Amanda’s family to be with her as much as possible during her hospitalization. And while Amanda did not survive her injuries, her parents’ decision to donate her organs and tissue provided the gift of life to seven people.
After Amanda’s death the Forsyth family realized how incredibly important the donated transportation had been during their ordeal. One day, Warren Forsyth watched as a woman who had just lost her daughter, waited in the rain for a bus to take her home from the hospital. He offered her and her son a ride home and so began the idea for their foundation, the Gift of Life Family Transport.
Today, the Gift of Life Family Transport provides families of organ donors in the New York City area with free 24-hour transportation during the donation period. Drivers are volunteers from the New York Police and Fire departments. To date, the Forsyth Family and the Foundation have provided transportation for more than 240 families most of whom have been donor families.
“Diane and Warren Forsyth have honored their daughter’s legacy by providing this service to other donor families,” said Martha Anderson, Executive VP Donor Services, MTF. “The Gift of Life Transport is such a compassionate program, relieving grieving families of significant stress during a very emotional time. It also is a superb educational resource providing information about organ and tissue donation to members of the New York Fire and Police Departments.”
On December 4, 2013, representatives from MTF joined New York Organ Donor Network in recognizing Warren and Diane as this year’s winner of The Nicholas Miller Award. The award is named after the eldest son of Thomas and Jayne Miller, a heart transplant recipient and then a cornea donor following his death at age two.
“The Nicholas Miller Award honors volunteers who have promoted organ and tissue donation and provided donor family support through advocacy and education. We believe the Forsyth family and the Gift of Life Family Transport truly exemplify these qualities, “ said George Herrera, Vice President, Donor Services, MTF.
The Musculoskeletal Transplant Foundation, a non-profit organization based in Edison, NJ, is a national consortium comprised of leading organ procurement organizations, tissue recovery organizations and academic medical institutions. Since its inception in 1987, MTF has received tissue from more than 100,000 donors and distributed more than 5 million grafts for transplantation. For more information, visit www.mtf.org
For more information on organ and tissue donation, visit www.donatelife.org
Michigan breast cancer survivor and tissue transplant recipient chosen to ride on Donate Life Float in Tournament of Roses Parade
Edison, NJ, November 2013 — The Musculoskeletal Transplant Foundation (MTF) announced today that Sue Herrick Pilon of Wyandotte, Michigan, a breast cancer survivor and tissue transplant recipient, will represent MTF on the Donate Life Float at the 2014 Tournament of Roses Parade in Pasadena, CA.
At age 52, Sue was diagnosed with breast cancer, the third generation of her family to battle the disease. Her maternal grandmother died of the disease but her mother, now deceased, was a 25-year survivor. It was her mother’s experience as a breast cancer survivor that greatly affected Sue’s attitude towards her diagnosis.
"When it was my turn to face this disease, I was determined to not just beat it. I wanted my life back completely. Breast reconstruction was not offered to my Mom and her quality of life wasn’t the same after cancer,” Pilon said.
“Given all the advances in breast cancer treatment and reconstruction options in the years since, I was certain there was a path available that would get rid of the cancer and yet allow me to get back to the way I looked and felt before the surgery.”
The University of Michigan Breast Cancer Center and Plastic Surgery Department provided the answer. Since Sue’s cancer was discovered very early, and her overall health was very good, she was a candidate for reconstructive surgery using a dermal allograft provided by MTF -- human tissue from a donor used to create a base on which breast implants could immediately be implanted. Her mastectomy and reconstruction all occurred on the same day and she left the hospital 24 hours later, cancer-free and not requiring any additional reconstruction.
“This is a tremendous gift I’ve been given. I am extremely aware and appreciative of the fact that a family, at the worst possible time, was asked if they were willing to make a gift of organs and tissue from their loved one, so that other people – strangers – might have a great quality of life after breast cancer without missing a beat. I thank my donor family in my heart every day,” said Pilon.
“We are delighted to sponsor Sue and to support the Donate Life Float at the Tournament of Roses Parade. Her story highlights the incredible gift of tissue donation and the importance of the work done at MTF," said Martha Anderson, Executive Vice-President, Donor Services.
There has been a Donate Life Float in the Rose Parade since 2004.
To see an interview with Sue, her husband and her surgeon visit: http://www.youtube.com/channel/UC3cXmU6SBvq3QG2Z8dc67AQ/videos
To find out more about breast reconstruction after mastectomy, visit http://www.mtf.org/bra_day_2013.html
The Musculoskeletal Transplant Foundation, a non-profit organization based in Edison, NJ, is a national consortium comprised of leading organ procurement organizations, tissue recovery organizations and academic medical institutions. Since its inception in 1987, MTF has received tissue from more than 100,000 donors and distributed more than 5 million grafts for transplantation.
Edison, NJ, July 11, 2013 — MTF, the Musculoskeletal Transplant Foundation, announced today that it is the first tissue bank to receive approvals to market human allografts in Australia under the new Australian Biologics Framework, implemented in May 2011.
The first two approved biologics in Australia are:
• DBX® Putty - an osteoinductive bone allograft processed from donated human tissue, specifically
designed to meet the Australian medical and regulatory requirements, and
• FlexHD® and FlexHD® Pliable –allografts processed from donated human skin and packaged in
an ethanol solution.
According to Bruce Stroever, MTF President & Chief Executive Officer, "These were complicated, multi-year projects and we are delighted that our facilities, processes and people have met the Australian Therapeutic Goods Act requirements. Of special note, our new in-process bioburden testing method and isolator technology were critical in achieving approval of DBX® from the Australian authorities.”
DBX®, a Demineralized Bone Matrix, is an allograft bone void filler used for the treatment of surgically created bone defects, or bone defects created from traumatic injuries. It can be used as a bone extender in orthopaedic, spine and trauma applications. DBX® has been approved for use in over 50 countries.
FlexHD® and FlexHD® Pliable are intended for use in the replacement of damaged or inadequate integumental tissue, or for the reinforcement or supplemental support of soft tissue defects. These allografts have been used extensively for hernia repair as well as for patients needing breast reconstruction following mastectomy.
Stroever noted that MTF’s quality and safety standards now meet or exceed the requirements of the American Association of Tissue Banks (AATB), US Food and Drug Administration (FDA) and the Australian Therapeutic Goods Administration (TGA).
The Musculoskeletal Transplant Foundation (www.MTF.org), one of the nation’s leading tissue bank, changes lives by connecting donors and transplant recipients. As a non-profit service organization, MTF is dedicated to providing quality tissue through a commitment to excellence in education, research, recovery and care for recipients, donors and their families. Since our inception in 1987, MTF has received tissue from more than 100,000 donors and distributed more than 5.5 million-grafts for transplantation.
Lewisville, Texas, July 1, 2013 — Orthofix International N.V., (Nasdaq: OFIX) (the Company) announced today in collaboration with the Musculoskeletal Transplant Foundation (MTF) the full market release of Trinity® ELITE™ Allograft with Viable Cells and VersaShield™ Amniotic Membrane tissue forms through both of its Spine Fixation and U.S. Extremity Fixation distribution channels. Trinity ELITE provides the unique feature of being fully moldable by the user, a key distinction of the proprietary technology that MTF developed.
Dr. Peter M. Shedden, MSc., M.D., FRCS(C), FACS, FAANS, of the Greater Houston Neurosurgery Center in The Woodlands, Texas and a member of the Company’s medical education team, stated, “In my initial usage of Trinity ELITE, I have been extremely satisfied with the ability to pack more graft material into a disc space during a posterior lumbar interbody fusion procedure, as well as posterior laterally. In addition, this novel allograft represents a new option for surgeons who want to apply a cell-based allograft to the lateral gutter and lay it flat along the transverse process.”
Orthofix President and Chief Executive Officer Brad Mason noted, “We are very excited about the initial feedback from the early adopters, which has been universally and extremely positive, as it confirms Trinity ELITE overcomes current challenges in graft containment and handling of cell-based tissue forms. Orthofix has long maintained its commitment to co-developing and commercializing such exciting technology with MTF, and we plan to continue being innovators in this space.”
Chief Executive Officer of the Musculoskeletal Transplant Foundation Bruce Stroever commented, “Over the last five years, the MTF/Orthofix partnership has proven to be a successful endeavor providing a new, viable cell tissue form to tissue recipients. We are pleased to release our newest innovation, Trinity ELITE. Trinity ELITE is the first fully moldable allograft with viable cells. This next generation allograft is the first cell-based offering of its kind designed to provide an enhanced handling experience and greatly improved graft containment properties.”
Trinity ELITE, a third generation allograft with viable cells, provides surgeons with a unique alternative to autograft, the standard for bone grafting. Trinity ELITE builds on the exemplary safety profile of more than 75,000 Trinity Evolution® procedures. Trinity ELITE offers an enhanced handling experience, while providing a viable grafting alternative.
The full market release of Trinity ELITE includes the launch into both spinal and extremity applications and is available in four different quantities.
Orthofix International N.V. is a diversified, global medical device company focused on developing and delivering innovative orthopedic solutions that drive value for patients, surgeons, and providers. Orthofix’s products are widely distributed around the world to surgeons and patients via Orthofix’s sales representatives and its subsidiaries, and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating on R&D activities with leading research and clinical organizations such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, and Texas Scottish Rite Hospital for Children. For more information about Orthofix, please visit www.orthofix.com.
About the Musculoskeletal Transplant Foundation (MTF):
The Musculoskeletal Transplant Foundation, the nation’s leading tissue bank, changes lives by connecting donors with surgeons and transplant recipients. As a non-profit service organization, MTF is dedicated to providing quality tissue through a commitment to excellence in education, research, recovery and care for recipients, donors and their families. Since its inception in 1987, MTF has recovered tissue from more than 100,000 donors and distributed over 5 million grafts for transplantation. For more information, please visit MTF's website at www.mtf.org.
Edison, NJ, June 19, 2013 — The Musculoskeletal Transplant Foundation (MTF) has announced the release of new sizes of its popular split thickness skin grafts, or STSG. The grafts are now available in sheet form, up to 16cm x 35cm, as opposed to long narrow strips that are commonly used. MTF is the first and only tissue bank in the country offering these wider grafts in ten convenient sizes, starting at 5 cm by 5 cm.
STSG grafts are used as a temporary dressing in partial thickness and full thickness burn wounds, acting as a protective barrier against environmental contaminants, promoting thermoregulation and controlling fluid loss. The new sheets support MTF’s mission by providing time–saving benefits to surgeons and decreasing discomfort for burn victims.
Health care professionals at the Burn Center at Wake Forest Baptist Medical Center in North Carolina recently used the new large split thickness grafts to cover the back of a burn patient. Dr. Ashley Mooney, MD, was extremely pleased with the results. “The wide grafts cut the operative time by a third,” she said.
“The larger sheet grafts will allow us to have fewer seams, which means less scarring and better cosmetic outcomes, especially in highly visible areas of the body, such as arms and legs. It will also result in less contracture across joints, resulting in fewer revisions and less OR time for the patient and the surgeon,” noted Timothy A. Johnson, RN, at the Burn Center.
In addition to STSG, MTF also offers acellular dermal grafts FlexHD® and FlexHD® PLIABLE™. FlexHD PLIABLE, which is specifically designed for use in breast reconstruction procedures, is derived from a deeper cut into the dermis tissue, making it more supple and elastic. The uppermost layer of dermis and epidermis from FlexHD PLIABLE donors can then be used to make the new wider STSG sheets. This ability to obtain two grafts, STSG Sheets and FlexHD PLIABLE, from the same donor is in keeping with MTF’s commitment to maximize each gift of donated tissue.
MTF’s new STSG sheet grafts not only have the advantage of being both wider and of more consistent thickness than other grafts available on the market today, but are all available in both meshed and non-meshed configurations.
MTF provides STSG to over 50 burn centers and hospitals in the US and New Zealand. In 2012, MTF distributed 2,750 STSG grafts.
MTF is part of the American Association of Tissue Banks Emergency Preparedness team that offers life-saving STSG grafts in response to worldwide tragedies, such as the wildfires in both Australia and Santa Barbara, California.
To inquire about these new grafts, contact Lisa Miller, Assistant Product Manager, MTF Dermal Division, at 1-800-946-9008 Ext 2379.
Breast reconstruction awareness increases with Angelina Jolie statement and new proposed legislation
Edison, NJ, May 16, 2013 — Actress Angelina Jolie attracted national attention when she revealed this week that she had undergone a double mastectomy for prophylactic reasons. Her announcement came at the same time as the "Breast Cancer Patient Education Act" (S. 931) was introduced in Congress. The legislation is supported by The American Society of Plastic Surgeons (ASPS), and the Plastic Surgery Foundation (PSF), originators of the Breast Reconstruction Awareness (BRA) campaign.
MTF, with the support of its recovery partners, joined with ASPS/The PSF to back the first national Breast Reconstruction Awareness day in 2012. As a sponsor, MTF joins the world’s largest organization of board-certified plastic surgeons in a campaign to support breast cancer survivors’ right to be informed about post-mastectomy breast reconstruction options.
According to the ASPS, since 1998, health plans that offer breast cancer coverage have been required to provide coverage for breast reconstruction and prostheses. Yet published research shows that many women eligible for breast reconstruction following breast cancer, minorities in particular, are not informed of the variety of care options. Approximately 232,340 women will be diagnosed with breast cancer in 2013, according to the American Cancer Society's most recent estimates for breast cancer in the United States.
The "Breast Cancer Patient Education Act" requires the Secretary of Health and Human Services to plan and implement an education campaign to inform women of the availability and coverage of breast reconstruction, prostheses and other options. The Secretary may develop information for distribution or may identify information prepared by other organizations. The educational materials would inform women that breast reconstruction is possible at the time of breast cancer surgery, it may be delayed until after other treatments, or they may choose not to have reconstruction and be informed of the availability of prostheses or breast forms. Also, educational materials would inform breast cancer patients that federal law mandates coverage of breast reconstruction, even if such reconstruction is delayed until after other treatments.
If you are having trouble viewing the video above, please click here. And be sure to share.
Edison, NJ, March 29, 2013 — The Musculoskeletal Transplant Foundation (MTF), one of the world's leading tissue banks announces the recipients of its 2013 Research Grants. Since 1987 the Musculoskeletal Transplant Foundation has been at the forefront of tissue research, with about $35 million awarded through 2012. MTF anticipates awarding close to $2 million in grants and awards in the 2013 calendar year. The 2013 grant recipients approved for funding are:
PEER REVIEW — ESTABLISHED INVESTIGATOR
Treena Arinzeh, Ph.D., New Jersey Institute of Technology, Biomimetic Scaffold for Cartilage Repair
Hani Awad, Ph.D., University of Rochester, Teriparatide and Allograft Cartilage Derived Matrix for Regenerative Repair of Articular Cartilage
Maria Siemionow, M.D., Ph.D., DSc, Cleveland Clinic, Novel Human Allograft Epineural Conduit for Restoration of Long Nerve Defects
J.R. NEFF AWARD
Francis Lee, M.D., Ph.D., Columbia University, Bio-Logical Modification of Structural Bone Allografts
PEER REVIEW – JUNIOR INVESTIGATOR
Daniel Boguszewski, Ph.D., University of California, Los Angeles, Comparing Tension Board Versus In Situ Preconditioning of Allograft Tissues used for Anterior Cruciate Ligament Reconstruction
Jared Bushman, Ph.D., Rutgers University, Local Immunosuppression and Enhancement of Peripheral Nerve Allografts
James Cray, Ph.D., Georgia Health Sciences University, Use of Stem Cells to Augment Growth Factor Therapies in Non-Healing Bony Defects
Jason Ko, M.D., University of Washington, Vascularized Composite Allotransplantation (VCA) of the Elbow: A Study of Vascular Perfusion and Technical Feasibility
X. Lucas Lu, Ph.D., University of Delaware, Early Weight Bearing in the Rehabilitation of Microfracture Surgery
PEER REVIEW – DERMAL
Deepak Narayan, M.D., Yale University, Tissue Engineering of Breast using Acellularized Cadaver Dermis and Pericytes
Mark Lee, M.D., University of California, Davis, Bioengineering Implantable Bone Tissue using Allogenic and Autologous Mesenchymal Stem Cells
Daniel Bracey, M.D., Wake Forest University Health Sciences, A Novel Xenograft-Derived Bone Scaffold for Improved Treatment of Critical Bone Defects
Jesse Otero, M.D., Ph.D. University of Iowa, The Role of Osteoclasts in the Growth and Metastasis of Chondrosarcoma: A Mammal Model
For more information on how you can apply for a research grant, contact Hans Burchardt, Ph.D., Vice-President, Scientific Affairs (570-496-3434) or Hans_Burchardt@MTF.org or visit the MTF website.
Edison, NJ, January 2013 – U.S. Rep. Frank Pallone, Jr. visited the MTF headquarters in Edison recently to learn more about tissue banking. MTF is one of the largest companies in the Congressman’s district, which includes two counties in Central New Jersey.
Rep. Pallone has represented central New Jersey in Congress since 1988. He is a senior member of the House Energy and Commerce Committee and serves as the top Democrat on the Committee's Subcommittee on Health. That committee has oversight of the U.S. Food and Drug Administration (FDA), one of MTF’s major regulatory agencies.
MTF’s senior management team, led by President and CEO Bruce Stroever, and Martha Anderson, Executive Vice President, Donor Services, provided information on MTF’s history, structure and mission. This was followed by a detailed discussion of how current and proposed tissue forms are regulated by the FDA. Mark Spilker, Executive Vice President, Research and Development, Quality Assurance and Regulatory Affairs led a discussion of MTF’s experience with the FDA, including a demonstration of several tissue forms.
Following the briefing, Rep. Pallone’s legislative aide, Tiffany Guarascio, joined MTF staffers for a tour of the Edison facility, including the processing rooms. Frank Wilton, Chief Executive Officer of the American Association of Tissue Banks (AATB) was also present for the meeting and tour.
Both Rep. Pallone and the MTF staff felt the meeting was very helpful as an educational event.
Edison, NJ, December 2012 –The Musculoskeletal Transplant Foundation announced today that eleven-year old Chase Caspersen of Boelus, NE, a cancer survivor and tissue transplant recipient, will represent MTF on the Donate Life Float at the 2013 Tournament of Roses Parade.
At the age of nine Chase was diagnosed with osteosarcoma in his right forearm. Two out of three doctors consulted recommended amputation, a frequent treatment for this disease in young people. But Dr. Sean McGarry, an orthopedic surgeon at the University Medical Center of Nebraska and member of the MTF's Medical Board of Trustees, brought the family hope with the possibility of a tissue transplant.
After nine hours of surgery Dr. McGarry was able to remove the tumor without damaging the growth plates in Chase’s arm. Surgical specialists at MTF used x-rays to match the donated graft with Chase. Dr. McGarry then transplanted donated bone and secured it with metal hardware, saving Chase's arm.
Today, Chase is an active sixth-grader playing baseball and video games. Grateful for his second chance and inspired by the service dogs that visited him in the hospital, Chase had the idea to sell dog toys to benefit pediatric cancer research. PetSmart made the program national and Chase hopes his initiative will help children for years to come.
"We are delighted to sponsor Chase and to support the Donate Life Float at the Tournament of Roses Parade. His story highlights the incredible gift of tissue donation and the importance of the work done at MTF," said Martha Anderson, Executive Vice-President, Donor Services.
There has been a Donate Life Float in the Rose Parade since 2004.
The Musculoskeletal Transplant Foundation, a non-profit organization based in Edison, NJ, is a national consortium comprised of leading academic medical institutions, organ procurement organizations and tissue recovery organizations. Since its inception in 1987, MTF has received tissue from more than 80,000 donors and distributed more than 4 million grafts for transplantation.
LifeShare Transplant Donor Services of Oklahoma, Inc and MTF Announce New Tissue Recovery Partnership
Edison, NJ, October 2012 – LifeShare Transplant Donor Services of Oklahoma, Inc. based in Oklahoma City, Oklahoma, announced that it has begun providing musculoskeletal tissue recovery services to the Musculoskeletal Transplant Foundation (MTF) whose corporate headquarters are based in Edison, New Jersey.
The two organizations entered into a tissue recovery agreement effective October 1, 2012. LifeShare serves as the federally designated organization dedicated to recovering organs for transplantation in all 77 counties of the state of Oklahoma.
“This partnership combines the key strengths of each of our organizations and allows for excellent client services. Additionally we will be able to improve the process of tissue donation for the families we serve as well as for the hospital staff and other healthcare professionals with whom we work”, stated Jeff Orlowski, CEO of LifeShare.
Bruce Stroever, MTF President and CEO, agreed. “Both organizations are like-minded in our altruistic missions. And because of MTF’s commitment to returning donor tissue to the local community, this new partnership will ensure that surgeons and hospitals in LifeShare’s service area will have priority access to tissue grafts provided by MTF.”
Edison, NJ, October 2012 –The Musculoskeletal Transplant Foundation (MTF) has announced that the foundation with the support of its Recovery Partners, have joined with the American Society of Plastic Surgeons (ASPS) and The Plastic Surgery Foundation (The PSF) in support of the first national Breast Reconstruction Awareness (BRA) Day USA on October 17, 2012. As a sponsor, MTF, the nation’s leading tissue bank, joins the world's largest organization of board-certified plastic surgeons in a campaign to support breast cancer survivors' right to be informed and to choose which breast reconstruction option, following mastectomy, is right for them.
Research shows that 7 out of 10 women diagnosed with breast cancer are not informed of their reconstructive options. In order to address this critical issue, the U.S. and 20 other countries will join together for BRA Day on October 17. BRA Day USA is an initiative designed to promote education, awareness and access regarding breast reconstruction following breast cancer surgery. MTF and its tissue recovery partners are joining this collaborative effort between the ASPS and The PSF.
“We are pleased to be a major national contributor to BRA Day USA,” noted Martha Anderson, MTF executive vice president. “At MTF we have been providing tissue grafts for transplant for 25 years and we understand the impact that reconstructive surgery can have on people’s lives. Thousands of women have been helped by the gift of donated skin, which can help complete the healing from the ravages of breast cancer. Honoring both the tissue donor and the recipient is part of our mission at MTF and this initiative reinforces our mission.
BRA Day for MTF website/2
“MTF and our recovery partners applaud this campaign to better educate those women who are faced with difficult decisions about their breast reconstruction options following mastectomy. BRA Day will help women make more informed choices and we are proud to be part of that effort.”
The Musculoskeletal Transplant Foundation (www.MTF.org), the nation’s leading tissue bank, changes lives by connecting donors and transplant recipients. MTF’s recovery partners include more than 30 leading organ procurement organizations and tissue banks in the U.S. and Canada. As a non-profit service organization, MTF is dedicated to providing quality tissue through a commitment to excellence in education, research, recovery and care for recipients, donors and their families. Since our inception in 1987, MTF has received tissue from more than 90,000 donors and distributed more than 5 million grafts for transplantation, including FlexHD, an acellular dermal matrix that is used in breast reconstruction.
Sponsoring Recovery Partners include:
California Transplant Donor Network
Donor Network of Arizona
Gift of Life Donor Program
Gift of Life Michigan
Legacy of Life Hawaii
LifeShare of Oklahoma
Midwest Transplant Network
Mississippi Organ Recovery Agency
New Jersey Sharing Network Foundation
Wisconsin Tissue Bank
About ASPS and The PSF
The American Society of Plastic Surgeons (ASPS) is the largest plastic surgery specialty organization in the world. Founded in 1931, the society is composed of board-certified plastic surgeons that perform cosmetic and reconstructive surgery. The mission of ASPS is to advance quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery. The Society advocates for patient safety, such as requiring its members to operate in accredited surgical facilities that have passed rigorous external review of equipment and staffing.
ASPS works in concert with The Plastic Surgery Foundation (The PSF), founded in 1948, which supports research, international volunteer programs and visiting professor programs. The foundation's mission is to improve the quality of life of patients through research and development. The PSF accomplishes its mission by providing invaluable support to the research of plastic surgery sciences through a variety of grant programs.
Edison, NJ, August 2012 – Joseph D. Zuckerman, M.D., the Walter A. L. Thompson Professor of Orthopaedic Surgery and Chair, Department of Orthopaedic Surgery at NYU Langone Medical Center, has been appointed to the Board of Directors of the Musculoskeletal Transplant Foundation (MTF).
Dr. Zuckerman graduated from Cornell University and received his medical degree from the Medical College of Wisconsin where he was selected for membership in the Alpha Omega Alpha Honor Society. He completed a residency in orthopedic surgery at the University of Washington Affiliated Hospitals, a fellowship in adult reconstructive surgery and arthritis research at Brigham and Women’s Hospital, and was a visiting clinician in shoulder surgery at the Mayo Clinic.
Dr. Zuckerman recently served as president of the American Academy of Orthopaedic Surgeons (AAOS), the world’s largest professional orthopaedic association. He has also served as president of the American Shoulder and Elbow Surgeons, and Chair of the Council on Education for the AAOS. He has received the “Teacher of the Year Award” five times from Hospital for Joint Disease orthopaedic residents, and in 2011 he was selected as a recipient of the Distinguished Teaching Award from NYU. He serves on the editorial boards of several medical journals and has authored 14 textbooks, 81 book chapters and over 300 scientific articles.
“We are honored and privileged to have Dr. Zuckerman join our Board” said Dr. William Tomford, Chair of the MTF Board of Directors. “Dr. Zuckerman is a world renowned orthopaedic surgeon. He will bring outstanding expertise and experience to the MTF Board as it continues to oversee the Foundation’s mission of providing the highest quality tissue grafts and advancing the science of transplantation.”
Musculoskeletal Transplant Foundation (MTF) Partners with CONMED/Linvatec for Sports Medicine Applications
Edison, NJ, January 2012 — MTF announced a new partnership with CONMED Corporation related to the promotion of sports medicine tissues and related products. CONMED’s subsidiary, CONMED Linvatec, will serve as the exclusive world-wide marketing representative for MTF’s sports medicine allograft tissues such as tendons, ligaments and cartilage. Additionally, CONMED Linvatec will assume responsibility for distribution of MTF’s Cascade Platelet-Rich Plasma (PRP) product which uses a patient’s own blood to aid in the healing process. MTF will continue to be responsible for donor suitability, processing, storage and distribution as well as invoicing hospitals and surgical centers for sports medicine allografts. Upon the close of the agreement, MTF’s current employees of the MTF Sports medicine marketing and surgical consultant group will become employees of CONMED Linvatec.
“CONMED is a very successful sports medicine company with a broad line of products centered around the arthroscopic approach to joint repair. The CONMED sales force of over 200 people will greatly expand our reach and access to the sports surgeon and should have a very positive effect on our tissue distribution in the coming years,” said Bruce Stroever, President and CEO of MTF. “CONMED recognizes how critically important it is for us to continue to educate medical professionals in the latest sports medicine repair techniques, and to continue to safeguard the public’s trust in tissue donation and transplantation.”
The Musculoskeletal Transplant Foundation, the leading tissue bank in the U.S. is dedicated to providing quality tissue through a commitment to excellence in education, research, recovery and care for recipients, donors and their families. Since its inception in 1987, MTF has received tissue from 90,000 donors and has provided more than 5 million tissue grafts for transplantation. Additional information is available at www.mtf.org.